排序方式: 共有66条查询结果,搜索用时 31 毫秒
1.
2.
3.
Joubert Bastien Belbezier Aude Haesebaert Julie Rheims Sylvain Ducray François Picard Géraldine Rogemond Véronique Psimaras Dimitri Berzero Giulia Desestret Virginie Honnorat Jérôme 《Journal of neurology》2020,267(7):2083-2089
Journal of Neurology - To assess the long-term outcomes of patients with temporal lobe epilepsy and CSF anti-glutamate decarboxylase antibodies (GAD65-Abs). We retrospectively analyzed the clinical... 相似文献
4.
5.
Ribeiro Monica Durand Thomas Roussel Martine Feuvret Loïc Jacob Julian Psimaras Dimitri Noel Georges Keller Audrey Bompaire Flavie Hoang-Xuan Khê Bernier Marie-Odile Godefroy Olivier Ricard Damien 《Journal of neuro-oncology》2020,148(2):335-342
Journal of Neuro-Oncology - Cognitive impairment is frequent in patients with high-grade glioma and requires cognitive follow-up. Cognitive screening tools such as the Montreal Cognitive Assessment... 相似文献
6.
7.
Villagrán-García Macarena Muñiz-Castrillo Sergio Ciano-Petersen Nicolás Lundahl Vogrig Alberto Farina Antonio Villard Marine Psimaras Dimitri Alentorn Agusti Gonçalves David Fabien Nicole Rogemond Véronique Joubert Bastien Honnorat Jérôme 《Journal of neurology》2023,270(1):283-299
Journal of Neurology - The link between paraneoplastic neurological syndromes (PNS) and renal cell and bladder cancer (RCC/BC) is rare and uncertain. Our aim was to clinically evaluate, in light of... 相似文献
8.
A. Idbaih S. Taillibert J.-M. Simon D. Psimaras H.-M. Schneble S. Lopez P. Lang T. Toubiana L. Feuvret J.-Y. Delattre J.-J. Mazeron 《Cancer radiothérapie》2008,12(8):788-792
PurposeThe optimal schedule of irradiation in elderly patients suffering from glioblastoma multiforme (GBM) is unsettled.Materials and methodsThis study reviewed the charts of 28 consecutive GBM patients aged 70 years or more with a Karnofsky Performance Status (KPS) greater than or equal to 70 who received a short course of radiotherapy (40 grays in 15 fractions over three weeks).ResultsThe median age at surgery was 74.6 years (range, 70.1–85.7). No patient received prior or concomitant chemotherapy. The median progression-free survival and overall survival were 21.6 weeks (95% CI, 17.0–39.9) and 50.6 weeks (95% CI, 26.3–62.0), respectively. Even within a narrow range (< 90 or ≥ 90), KPS remained a prognostic factor (p = 0.03). Tolerance appeared acceptable in terms of KPS changes and corticosteroid use during radiation therapy.ConclusionThese results support the efficacy of short schedule radiotherapy for GBM in elderly patients with a good KPS. 相似文献
9.
10.